Primary Biliary Cholangitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Primary Biliary Cholangitis (PBC) and your doctor has offered you treatment with a medicine called bezafibrate
Who may not be able to join:
- You are under 18 years old
- Your life expectancy is estimated to be less than 6 months
- You have been diagnosed with cancer
- You are expected to have a liver transplant within the next 6 months
- You have another type of liver disease, such as one caused by a virus, an autoimmune condition, alcohol, or a condition involving fat build-up in the liver (sometimes called fatty liver disease)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Henning Grønbæk, Prof, MD, Aarhus University Hospital
Phone: +45 21679281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment effect on sCD163 levels; Treatment effect on levels of fibrosis markers; Treatment effect on liver stiffness; Treatment effect on bile acid composition
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.